Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The CEBIFOX Trial

Autor: Kasper, Stefan, Meiler, Johannes, Knipp, Heike, Höhler, Thomas, Reimer, Peter, Steinmetz, Tilman, Berger, Winfried, Linden, Gabriele, Reis, Henning, Markus, Peter, Paul, Andreas, Dechêne, Alexander, Schumacher, Brigitte, Kostbade, Karina, Virchow, Isabel, Ting, Saskia, Worm, Karl, Schmid, Kurt W., Herold, Thomas, Wiesweg, Marcel, Schuler, Martin, Trarbach, Tanja
Zdroj: In Clinical Colorectal Cancer December 2020 19(4):236-247
Databáze: ScienceDirect
Externí odkaz: